Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK. - Wikidata - awgldk - TriplyDB

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.

http://www.wikidata.org/entity/Q37342850

about

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma Effect of lentivirus-mediated survivin transfection on the morphology and apoptosis of nucleus pulposus cells derived from degenerative human disc in vitro Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors Cytotoxic and Antioxidant Activity of a Set of Hetero Bicylic Methylthiadiazole Hydrazones: A Structure-Activity Study Cadmium Activates Multiple Signaling Pathways That Coordinately Stimulate Akt Activity to Enhance c-Myc mRNA Stability.Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy.Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.Low zinc environment induces stress signaling, senescence and mixed cell death modalities in colon cancer cells.Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.Molecularly targeted therapies for p53-mutant cancers.Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.MKK3 as oncotarget Targeting of non-oncogene addiction.The nucleotide excision repair protein XPC is essential for bulky DNA adducts to promote interleukin-6 expression via the activation of p38-SAPK.MKP1: Jekyll and Hyde for E1A.t-BuOOH induces ferroptosis in human and murine cell lines.trans-4,4'-Dihydroxystilbene (DHS) inhibits human neuroblastoma tumor growth and induces mitochondrial and lysosomal damages in neuroblastoma cell lines.Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α.Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice.Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase pathway.Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach.Age-dependent regulation of antioxidant genes by p38α MAPK in the liver.p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer.Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87 p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis

P2860

Q26742078-7F76F54E-3817-4F41-8136-F37FFCE6D3D2 Q27684879-3E2DB972-D76B-455B-AF31-D3FF73B8BD20 Q28082497-BF7B2EEA-783F-4F66-919B-7E43508B29C0 Q28829677-97F23E98-5795-417A-AA92-8FE96D8799D9 Q34008781-9E20AFC5-4AEF-4BFF-BE0E-937DAD59600B Q34281252-7E443023-6077-419D-99EC-14D52BCF3E66 Q34570398-C6D8ECC5-719D-499D-9E4A-B4AE68BDA40D Q35827627-86AF121D-89AE-47C6-B204-CAF31970032A Q35832158-C304D1EF-607F-4E06-BE79-7E3FD01F0A64 Q35843774-42C8532C-F647-4759-B575-96BFE0F8A74F Q35889906-45AE9AC2-2256-459F-AEA3-B103075AD4CD Q36041749-4F19FB60-1AEB-4D7D-AB7E-796788EE1F7F Q36918028-793BB599-6E6E-4EFA-829C-4350DD1C5980 Q37414070-9D578137-05FF-48CF-951B-9C235C415977 Q38366515-11AF6CCD-66BF-4277-955A-7292CE8AA70F Q38810052-5443E1FA-2187-438D-80E4-E9D06593308E Q38829592-F133ECC8-CCA5-4763-95AE-FF8F68034FD9 Q38868212-595075AA-A683-4A70-90D2-976C56AFB5E5 Q39393193-2EDC2053-2B72-4BA8-8B5F-BE9BC2B5881F Q41636987-9974A7A2-B9FF-4B6B-89F9-588CD25FAEFE Q42583176-2DB511E8-4A40-4EAF-8433-88A2A695B4EA Q42726616-E8817418-0514-4177-95CC-6A12F7E85340 Q42827201-05A6F1C7-8887-428C-9878-37312695B842 Q42957913-4FC052A8-ECBC-4091-AF2C-DBF76603B793 Q46295503-767D51BC-DA4F-4602-A73B-4E3B8F730ECE Q47137457-93114C89-2C48-4ED5-8CE2-A81D99D165CD Q47241645-1CF3FBE5-8A18-4DF3-96D5-9EB23DFA8323 Q47951320-CE0616A3-EE4D-4074-8B0A-7240E4F74FA7 Q49939655-3F853F32-C492-4064-887C-D97814C96E95 Q52719999-4F7BED10-C02D-4895-AB17-4722700EC614 Q54259614-F9A1E362-6D6D-4E87-9C97-4D58E3DD2A09 Q54981824-1D0B694E-8C6D-4422-A39C-433CFCAE6CB6 Q55511623-A65A2331-CA70-4145-8E66-CEBB45BE79F9 Q57071952-B9DCD4CD-7DC1-44BE-918B-636DB2F933F1 Q57278317-5159F9BB-1E2A-472A-8F0A-B38A282B752E

P2860

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.

http://www.wikidata.org/entity/Q37342850

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@en

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@nl

type

label

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@en

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@nl

prefLabel

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@en

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@nl

P1433

Q37342850-D6573065-3E7F-4D74-AB9F-F9582B594598

P1476

Q37342850-64EB7EDE-FAE3-4A00-98A5-825F37433A12

P2093

Q37342850-323D7FB6-5342-41AB-93F0-F205AF06271F

Q37342850-33038248-AD7D-4921-BA3F-9F2860F0FE92

Q37342850-38C0E068-657A-4BD0-87C6-21B875397924

Q37342850-76F41AF8-2FE8-4EA6-B410-75C4EBBB6FB8

Q37342850-9DF3E5D0-6B7E-4DC7-815F-E9C876CEE714

P2860

Q37342850-054EC35C-D5AE-4E34-B86B-E29944AACBD2

Q37342850-1B4BE2F7-086F-415B-A635-4A893BAAB85B

Q37342850-1EEA3E01-8A7D-4FC9-AA40-DFC9C117B109

Q37342850-2479F972-97F7-437E-BA3A-757A2B95C194

Q37342850-24D5844A-1507-443B-9D2A-2F0F816286A0

Q37342850-252C632A-D850-40CF-B329-6581F173ECD6

Q37342850-2D9EAD50-5BA4-4131-875A-5D2DD5AF75CE

Q37342850-3085E0A2-DAC5-47D2-A182-8EA693D6C8DA

Q37342850-33DE94DA-0290-4E37-BB53-18BD9ECCEC06

Q37342850-37EF9E3A-5467-4FD2-9E91-7A445AFABDB2

P304

Q37342850-0C8CD8F4-D495-490C-9DB5-FC855B8965FF

P31

Q37342850-18D9E3D4-51C6-44F2-A1B8-84C0A0DC330C

P356

Q37342850-85719230-1B57-4446-B3FA-58354A85D48F

P433

Q37342850-9DB12228-D9DE-4189-99B3-2F6847207DA9

P478

Q37342850-052F0BB6-D0A6-4B4C-845F-3BB698934384

P577

Q37342850-E90D8EBC-254C-4765-A987-6C45050D8D73

P5875

Q37342850-3CF117EC-ABDA-4B2C-A414-1D5C9D84DB8C

P698

Q37342850-B863ACE2-4D05-41E6-9EAC-F4F6973BEB1C

P921

Q37342850-E0B7B327-291D-49E7-8BBF-4E94E7E68571

P932

Q37342850-322B9FA7-54A1-4E50-9CC2-D407C319A3C6

P356

P1433

EMBO Molecular Medicine

P1476

Inhibition of p38 MAPK sensiti ...... active oxygen species and JNK.

@en

P2093

Ana Igea

http://www.w3.org/2001/XMLSchema#string

Angel R Nebreda

http://www.w3.org/2001/XMLSchema#string

Begoña Canovas

http://www.w3.org/2001/XMLSchema#string

Ignacio Dolado

http://www.w3.org/2001/XMLSchema#string

Lorena Pereira

http://www.w3.org/2001/XMLSchema#string

P2860

Cell transformation by the superoxide-generating oxidase Mox1

RETRACTED: Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804

Signal transduction by the JNK group of MAP kinases

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC

Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

P304

1759-1774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201302732

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257649006

http://www.w3.org/2001/XMLSchema#string

P698

24115572

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3840490

http://www.w3.org/2001/XMLSchema#string